TTNPB

CAS No. 71441-28-6

TTNPB( TTNPB | Ro 13-7410 | Ro-13-7410 | Arotinoid acid )

Catalog No. M17576 CAS No. 71441-28-6

TTNPB, a potent RAR agonist, inhibits binding of [3H]tRA of human RARα (IC50: 5.1 nM), β (IC50: 4.5 nM), and γ (IC50: 9.3 nM), respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
2MG 31 In Stock
5MG 49 In Stock
10MG 75 In Stock
25MG 157 In Stock
50MG 300 In Stock
100MG 454 In Stock
200MG Get Quote In Stock
500MG 986 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TTNPB
  • Note
    Research use only, not for human use.
  • Brief Description
    TTNPB, a potent RAR agonist, inhibits binding of [3H]tRA of human RARα (IC50: 5.1 nM), β (IC50: 4.5 nM), and γ (IC50: 9.3 nM), respectively.
  • Description
    TTNPB is a selective and highly potent agonist of retinoic acid receptors (RAR) α, β, and γ.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TTNPB | Ro 13-7410 | Ro-13-7410 | Arotinoid acid
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    RARα| RARβ| RARγ| RARγ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    71441-28-6
  • Formula Weight
    348.48
  • Molecular Formula
    C24H28O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 11.25 mg/mL. 32.28 mM;
  • SMILES
    c12c(C(CCC2(C)C)(C)C)ccc(c1)/C(=C/c1ccc(cc1)C(=O)O)/C
  • Chemical Name
    4-[(E)-2-(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pignatello MA, et al. Toxicol Appl Pharmacol. 1997, 142(2), 319-327.
molnova catalog
related products
  • Apilimod mesylate

    Apilimod mesylate is a potent?IL-12/IL-23?inhibitor.

  • α-Conotoxin EI

    α-Conotoxin EI is a selective nicotinic acetylcholine α1β1γδ receptor (nAChR) antagonist (IC50=187 nM) and an α3β4 receptor inhibitor. α-Conotoxin EI can block muscle and ganglionic receptors.

  • Hodostin

    Neostigmine methyl sulfate is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.